VVUS -- about to break out!# Stock
g*e
1 楼
From my blog:
http://www.mitbbs.com/pc/pccon_12673_259271.html
Current price: $13.75
Resistence levels: $15, $20
Target price: $28 if successful REMS revision to include retail distribution
from FDA in mid April
In JPM conference tomorrow, CEO Leland Wilson most likely will provide
updates about steady progress on script writing and mail order.
Other near term catalysts:
1. Q4 2012 Qsymia sale;
2. FDA decision on REMS revision to include retail distribution in Mid April;
3. Appeal the decision from the CHMP, A new decision in expected in second Q
of 2013;
4. Partnership announcement if item 2 successful
Personally I believe highly likely we will have positive outcomes on items 1
, 2 and 4. Long and strong on VVUS!
YMYD, do your own DD before investing.
http://www.mitbbs.com/pc/pccon_12673_259271.html
Current price: $13.75
Resistence levels: $15, $20
Target price: $28 if successful REMS revision to include retail distribution
from FDA in mid April
In JPM conference tomorrow, CEO Leland Wilson most likely will provide
updates about steady progress on script writing and mail order.
Other near term catalysts:
1. Q4 2012 Qsymia sale;
2. FDA decision on REMS revision to include retail distribution in Mid April;
3. Appeal the decision from the CHMP, A new decision in expected in second Q
of 2013;
4. Partnership announcement if item 2 successful
Personally I believe highly likely we will have positive outcomes on items 1
, 2 and 4. Long and strong on VVUS!
YMYD, do your own DD before investing.
